Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy

ClinicalTrials.gov ID: NCT05604170

Public ClinicalTrials.gov record NCT05604170. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 5:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC OLE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 3, global, open-label extension (OLE) study of adjunctive GNX treatment in children and adults with TSC who previously participated in either Study 1042-TSC-3001 or Study 1042-TSC-2001

Study identification

NCT ID
NCT05604170
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Marinus Pharmaceuticals
Industry
Enrollment
117 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
1 Year to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 16, 2022 (Actual)
Primary completion
Apr 2, 2025 (Actual)
Completion
Apr 2, 2025 (Actual)
Last update posted
Oct 1, 2025

2022 – 2025

United States locations

U.S. sites
20
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
Arkansas Children's Research Institute Little Rock Arkansas 72202 —
UCLA Mattel Children's Hospital, TSC Center Los Angeles California 90095 —
Children's Hospital of Orange County Orange California 92868 —
Rady Children's Hospital - San Diego San Diego California 92123 —
Children's Hospital Colorado Aurora Colorado 80045 —
Nemours Children's Hospital - Delaware Valley Wilmington Delaware 19803 —
Boston Children's Hospital, Harvard Medical School Boston Massachusetts 02115 —
Mayo Clinic - Rochester Rochester Minnesota 55905 —
Children's Mercy Hospital Kansas City Missouri 64108 —
University of Rochester Medical Center Rochester New York 14642 —
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599 —
Atrium Health/Levine Children's Hospital Charlotte North Carolina 28207 —
Duke University Medical Center Durham North Carolina 27712 —
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 —
Le Bonheur Children's Hospital Memphis Tennessee 38103 —
Child Neurology Consultants of Austin (CNCA) Austin Texas 78757 —
University of Texas Southwestern Medical Center Dallas Texas 75207 —
McGovern Medical School at the University of Texas Health Science Center Houston Texas 77030 —
University of Utah Health Care-Pediatric Neurology Salt Lake City Utah 84108 —
Seattle Children's Hospital Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05604170, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 1, 2025 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05604170 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →